c-Abl activates p38 MAPK independently of its tyrosine kinase activity: Implications in cisplatin-based therapy
International Journal of Cancer (2008) - Comments
doi: 10.1002/ijc.23063  issn: 0020-7136  pubmed: 17893873  issn: 1097-0215 

Eva M. Galan-Moya, Javier Hernandez-Losa, Clara I. Aceves Luquero, Miguel A. De La Cruz-Morcillo, Carmen Ramírez-Castillejo, Juan L. Callejas-Valera, Angel Arriaga, Antonio Fernandez Aranburo, Santiago Ramón Y Cajal, J. Silvio Gutkind, Ricardo Sánchez-Prieto